Brazil adopts BC Treatment as Prevention HIV strategy

The Treatment as Prevention (TasP) strategy pioneered by the BC Centre for Excellence in HIV/AIDS (BC-CfE ) has been adopted by Brazil as the country’s national HIV/AIDS policy. 

In October, Brazil joined France as the second country that month to announce plans to adopt TasP, which involves widespread HIV testing and the immediate offer of highly active antiretroviral therapy (HAART) to people testing positive for HIV. Treatment has been shown to virtually eliminate progression of the disease to AIDS and premature death, and also stops transmission of the virus.

The strategy was introduced by the BC-CfE in 2006, and endorsed by the Joint United Nations Programme on HIV/AIDS (UNAIDS) in 2010. China became the first nation to embrace the strategy in 2011, and was identified by the US as a key strategy to achieve an AIDS-free generation in 2012. In July 2013, the World Health Organization incorporated TasP in their new Global HIV Treatment Guidelines. 

BC was the first jurisdiction in Canada to implement TasP, coinciding with a simultaneous increase in harm reduction efforts including needle distribution, opioid substitution treatment, and supervised injection services. Since 1995 BC has seen HIV-related morbidity and mortality decline by more than 90%. Over the same time period, the number of new HIV diagnoses fell from more than 800 per year in 1995 to 238 in 2012. BC remains the only province in Canada to implement TasP and demonstrate a consistent decline in new cases of HIV.

. Brazil adopts BC Treatment as Prevention HIV strategy . BCMJ, Vol. 55, No. 10, December, 2013, Page(s) - News.

Above is the information needed to cite this article in your paper or presentation. The International Committee of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

About the ICMJE and citation styles

The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.

An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.

BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:

  • Only the first three authors are listed, followed by "et al."
  • There is no period after the journal name.
  • Page numbers are not abbreviated.

For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit

BCMJ Guidelines for Authors

Leave a Reply